Facebook Facebook Share

Professor Nigel Sparrow, OBE

Professor Nigel Sparrow OBE

"The Target Ovarian Cancer GP Advisory Board works to drive forward improvements in the early diagnosis of ovarian cancer. Ensuring more women are diagnosed sooner is critical if we are to see significant improvements in survival rates for ovarian cancer." 

Our GP Advisory Board brings together leading GPs from around the UK, with the aim of improving outcomes in early diagnosis for women.

With expertise in symptoms research, health economics, access to diagnostics and GP education, the Board will advise and shape our future work increasing early diagnosis and reducing risk.

Report on regional variation

The Board wanted to find out more about variation in the diagnosis of ovarian cancer across England. To do this they commissioned a piece of research looking at differences in the numbers of CA125 blood tests ordered, the time taken to complete non-obstetric ultrasounds, stage at diagnosis and one year survival rates for different parts of England.

Read the GP Advisory Board’s report, Regional variation in the diagnosis of ovarian cancer in England, which reveals and explores the reasons for these significant regional differences.

Regional variation in the diagnosis of ovarian cancer in England

​Target Ovarian Cancer's GP Advisory Board members

Read our most recent GP news

Monday 10 February 2014
The government’s regional ovarian cancer awareness programme launched in the North West of England: feeling bloated most days for three weeks or more, is the focus of a new Be Clear on Cancer programme launched by Public Health England today. Start of awareness programme Target Ovarian Cancer, who...
Monday 27 January 2014
Vicki, a GP from Northamptonshire, ran the Virgin Money London Marathon for Target Ovarian Cancer in April 2013. Here she shares her experience of taking part, and some advice for our current and future marathon runners. I'll make some assumptions: You've not done a marathon before and you're not a...
Monday 9 December 2013
This week we’re publishing our Annual Review which looks back on the progress made during the financial year 2012-13. I’m pleased that, together, we’re continuing to make such a big impact and in all of the key areas of our work – earlier diagnosis, better treatments, more support. We reached over...
Monday 11 November 2013
Target Ovarian Cancer welcomes the 2013 update of the Scottish Intercollegiate Guidelines Network (SIGN) on the management of epithelial ovarian cancer.The charity was pleased to have input into the draft guidance, highlighting the importance of including specific guidance to GPs on diagnostic...